Literature DB >> 16269024

Number V Oral lichen planus: clinical features and management.

D Eisen1, M Carrozzo, J-V Bagan Sebastian, K Thongprasom.   

Abstract

Oral lichen planus (OLP) is a relatively common chronic inflammatory disorder affecting stratified squamous epithelia. Whereas in the majority of instances, cutaneous lesions of lichen planus (LP) are self-limiting and cause itching, oral lesions in OLP are chronic, rarely undergo spontaneous remission, are potentially premalignant and are often a source of morbidity. Current data suggest that OLP is a T cell-mediated autoimmune disease in which auto-cytotoxic CD8+ T cells trigger apoptosis of oral epithelial cells. The characteristic clinical aspects of OLP may be sufficient to make a correct diagnosis if there are classic skin lesions present. An oral biopsy with histopathologic study is recommended to confirm the clinical diagnosis and mainly to exclude dysplasia and malignancy. The most commonly employed and useful agents for the treatment of lichen planus (LP) are topical corticosteroids but other newer agents are available.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269024     DOI: 10.1111/j.1601-0825.2005.01142.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  71 in total

1.  Amalgam contact hypersensitivity lesion: an unusual presentation-report of a rare case.

Authors:  Bk Ramnarayan; Pm Maligi; T Smitha; Us Patil
Journal:  Ann Med Health Sci Res       Date:  2014-09

2.  Direct Immunofluorescence in Oral Lichen Planus.

Authors:  Waranun Buajeeb; Nis Okuma; Supanee Thanakun; Titikarn Laothumthut
Journal:  J Clin Diagn Res       Date:  2015-08-01

3.  Gustatory function and taste perception in patients with oral lichen planus and tongue involvement.

Authors:  Valerie G A Suter; Simona Negoias; Hergen Friedrich; Basile N Landis; Marco-Domenico Caversaccio; Michael M Bornstein
Journal:  Clin Oral Investig       Date:  2016-06-06       Impact factor: 3.573

Review 4.  Vulvovaginal gingival lichen planus: report of two cases and review of literature.

Authors:  A Lucchese; A Dolci; G Minervini; C Salerno; D DI Stasio; G Minervini; L Laino; F Silvestre; R Serpico
Journal:  Oral Implantol (Rome)       Date:  2016-11-13

5.  Clinical evaluation of the efficiency of low-level laser therapy for oral lichen planus: a prospective case series.

Authors:  Adriana Cafaro; Paolo Giacomo Arduino; Gianluca Massolini; Ercole Romagnoli; Roberto Broccoletti
Journal:  Lasers Med Sci       Date:  2013-04-03       Impact factor: 3.161

6.  Salivary and serum interleukin-18 in patients with oral lichen planus: a study in an ethnic Chinese population.

Authors:  Yuanyuan Zhang; Wenzhao Liu; Songtao Zhang; Hongxia Dan; Rui Lu; Fang Wang; Jing Wang; Min Zhou; Xin Zeng; Mei Lin; Qianming Chen; Yu Zhou
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 7.  Evaluation of different diagnostic criteria of diseases manifesting the oral cavity - A review. Part-1.

Authors:  Peeyush Shivhare; Ashish Gupta; Monu Yadav; Arvinda Konidena; Lata Shankarnarayan
Journal:  J Oral Biol Craniofac Res       Date:  2016-01-20

8.  A comparative study of toluidine blue-mediated photodynamic therapy versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus: a randomized clinical controlled trial.

Authors:  Hasan Hoseinpour Jajarm; Farnaz Falaki; Majid Sanatkhani; Meysam Ahmadzadeh; Farzaneh Ahrari; Hooman Shafaee
Journal:  Lasers Med Sci       Date:  2014-12-09       Impact factor: 3.161

9.  Topical pimecrolimus versus betamethasone for oral lichen planus: a randomized clinical trial.

Authors:  Ola M Ezzatt; Iman M Helmy
Journal:  Clin Oral Investig       Date:  2018-06-16       Impact factor: 3.573

10.  Treatment of symptomatic oral lichen planus (OLP) with 0.1% tacrolimus powder in Oraguard-B - A pilot prospective study.

Authors:  Upender Malik; Siddharth Gupta; Shilpa D Malik; Shirin Vashishth; M S Raju
Journal:  Saudi Dent J       Date:  2012-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.